TheraVitae is a private, multinational company focused on using stem cells from the patient's own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has developed a proprietary stem cell technology, 'VesCell', that is currently being used by hospitals in Thailand and Singapore to treat patients with heart disease and peripheral artery disease.
| Website | http://www.theravitae.com |
| Revenue | $12.7 million |
| Employees | View employees |
| Phone | +66 2 664 4290 |
| Industry | Hospitals & Clinics, Healthcare |
| Competitors | Regenexx Physicians, Cure Medical, APEX Biologix, Celularity Inc., Orthofix, Tissue Regenix Group, Biocell Center Corp., Athersys, BioLife Sciences, Organogenesis +42 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 804 Companies |
| NAICS | NAICS Code 621 Companies, NAICS Code 6213 Companies, NAICS Code 621399 Companies, NAICS Code 62 Companies, NAICS Code 62139 Companies |
Looking for a particular TheraVitae employee's phone or email?
TheraVitae Questions
The TheraVitae annual revenue was $12.7 million in 2026.
The NAICS codes for TheraVitae are [621, 6213, 621399, 62, 62139].
The SIC codes for TheraVitae are [80, 804].
G2Crowd Trusted
300K+
Plugin Users
